MeSH term
Frequency | Condition_Probility | Adult | 4 | 0.0 |
Humans | 98 | 0.0 |
Male | 8 | 0.0 |
Middle Aged | 5 | 0.0 |
Animals | 41 | 0.0 |
*Colorectal Neoplasms/diagnosis/metabolism/pathology/therapy | 2 | 3.0 |
Cell Cycle Proteins/metabolism | 7 | 2.0 |
Cells, Cultured | 3 | 0.0 |
Comparative Study | 9 | 0.0 |
Fluorescent Antibody Technique | 2 | 0.0 |
Hela Cells | 35 | 0.0 |
Immunoblotting | 6 | 0.0 |
Mice | 10 | 0.0 |
Mitosis/physiology | 4 | 4.0 |
Protein-Serine-Threonine Kinases/genetics/*metabolism | 3 | 1.0 |
RNA Interference | 4 | 1.0 |
Rats | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 67 | 0.0 |
Ubiquitin-Protein Ligase Complexes/metabolism | 2 | 40.0 |
Antineoplastic Agents/*pharmacology | 2 | 0.0 |
Cell Cycle/drug effects | 3 | 0.0 |
Cell Division | 5 | 0.0 |
Enzyme Induction | 2 | 0.0 |
Mitosis/drug effects | 2 | 1.0 |
Base Sequence | 9 | 0.0 |
Blotting, Western | 14 | 0.0 |
CDC2 Protein Kinase/*metabolism | 2 | 1.0 |
Cell Cycle | 7 | 0.0 |
Centrosome/*metabolism | 3 | 15.0 |
DNA Primers | 7 | 0.0 |
Molecular Sequence Data | 13 | 0.0 |
Precipitin Tests | 7 | 0.0 |
Protein Kinases/genetics/*physiology | 3 | 18.0 |
Research Support, U.S. Gov't, P.H.S. | 25 | 0.0 |
Chromosome Aberrations | 2 | 0.0 |
Mitosis | 17 | 3.0 |
Mitotic Spindle Apparatus/*physiology | 2 | 11.0 |
Protein Kinases/chemistry/genetics/*metabolism | 4 | 26.0 |
Tumor Cells, Cultured | 15 | 0.0 |
Cell Cycle Proteins/*metabolism | 4 | 1.0 |
Cell Nucleus/*metabolism | 2 | 0.0 |
Cyclin B/metabolism | 7 | 7.0 |
Phosphorylation | 27 | 0.0 |
Protein Kinases/*metabolism | 16 | 4.0 |
Protein Transport | 3 | 0.0 |
Serine | 2 | 2.0 |
Cell Line | 12 | 0.0 |
Cell-Free System | 2 | 0.0 |
Enzyme Activation | 4 | 0.0 |
*G2 Phase | 3 | 8.0 |
*Mitosis | 6 | 4.0 |
Protein Structure, Tertiary | 9 | 0.0 |
Protein-Serine-Threonine Kinases/metabolism | 4 | 0.0 |
Ubiquitin/*metabolism | 2 | 1.0 |
Xenopus | 9 | 1.0 |
*Xenopus Proteins | 4 | 1.0 |
Cell Cycle Proteins/genetics/*metabolism | 2 | 1.0 |
Cell Line, Tumor | 8 | 0.0 |
Protein Kinases/genetics/*metabolism | 7 | 8.0 |
*DNA Damage | 8 | 1.0 |
Flow Cytometry | 6 | 0.0 |
Fluorescent Antibody Technique, Indirect | 4 | 0.0 |
DNA/metabolism | 4 | 0.0 |
Models, Biological | 7 | 0.0 |
Mutation | 8 | 0.0 |
Protein Binding | 14 | 0.0 |
Protein-Serine-Threonine Kinases/*chemistry/*metabolism | 2 | 8.0 |
Recombinant Proteins/metabolism | 7 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 4 | 0.0 |
Serine/chemistry | 3 | 2.0 |
Transfection | 17 | 0.0 |
*Cell Cycle Proteins | 5 | 0.0 |
*Protein Kinase Inhibitors | 8 | 12.0 |
*Protein Kinases | 3 | 4.0 |
Protein-Serine-Threonine Kinases/*physiology | 4 | 3.0 |
*Anaphase | 3 | 50.0 |
G2 Phase/drug effects | 2 | 4.0 |
Phosphorylation/drug effects | 4 | 0.0 |
Cell Nucleus/metabolism | 3 | 0.0 |
Cytoplasm/metabolism | 2 | 0.0 |
Immunohistochemistry | 8 | 0.0 |
Metaphase | 2 | 1.0 |
Protein Kinases/*physiology | 2 | 3.0 |
Time Factors | 9 | 0.0 |
Adenoviridae/genetics | 2 | 0.0 |
Cell Cycle Proteins/*genetics | 2 | 1.0 |
Female | 9 | 0.0 |
Microscopy, Fluorescence | 6 | 0.0 |
Mitosis/*genetics | 2 | 5.0 |
*CDC2-CDC28 Kinases | 2 | 0.0 |
Cyclin-Dependent Kinases/metabolism | 3 | 0.0 |
*Drosophila Proteins | 5 | 0.0 |
Macromolecular Substances | 3 | 0.0 |
*Saccharomyces cerevisiae Proteins | 2 | 0.0 |
CDC2 Protein Kinase/metabolism | 5 | 3.0 |
Enzyme Inhibitors/pharmacology | 4 | 0.0 |
cdc25 Phosphatase/metabolism | 2 | 3.0 |
Phosphoric Monoester Hydrolases/metabolism | 2 | 2.0 |
Protein Kinases/metabolism | 5 | 1.0 |
Protein-Serine-Threonine Kinases/*metabolism | 2 | 0.0 |
3T3 Cells | 2 | 0.0 |
COS Cells | 5 | 0.0 |
Cell Division/drug effects | 5 | 0.0 |
Mitosis/drug effects/*physiology | 2 | 18.0 |
Okadaic Acid/pharmacology | 2 | 2.0 |
Hela Cells/cytology | 2 | 25.0 |
Mitosis/*physiology | 7 | 7.0 |
Antineoplastic Agents/pharmacology | 2 | 0.0 |
Enzyme Inhibitors/*pharmacology | 2 | 0.0 |
Mice, Nude | 2 | 0.0 |
*Gene Expression Profiling | 3 | 0.0 |
Gene Library | 2 | 0.0 |
Prognosis | 4 | 0.0 |
Protein Kinases/*genetics | 3 | 2.0 |
Protein Kinases/physiology | 2 | 4.0 |
Green Fluorescent Proteins | 4 | 0.0 |
Histones/metabolism | 3 | 1.0 |
Luminescent Proteins/metabolism | 3 | 0.0 |
Plasmids/metabolism | 2 | 0.0 |
Binding Sites | 7 | 0.0 |
G1 Phase | 2 | 0.0 |
Models, Genetic | 2 | 0.0 |
*Gene Expression Regulation, Neoplastic | 4 | 0.0 |
Oligonucleotide Array Sequence Analysis | 3 | 0.0 |
RNA, Neoplasm/genetics | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Signal Transduction | 3 | 0.0 |
Enzyme Activation/genetics | 2 | 2.0 |
Substrate Specificity | 3 | 0.0 |
Insects | 2 | 1.0 |
Protein-Tyrosine Kinase/metabolism | 2 | 0.0 |
Ubiquitin/metabolism | 3 | 1.0 |
Aged | 4 | 0.0 |
Protein Kinases/*biosynthesis | 4 | 50.0 |
Blotting, Northern | 3 | 0.0 |
Plasmids/genetics | 2 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Promoter Regions (Genetics) | 3 | 0.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Phosphoproteins/genetics/*metabolism | 2 | 1.0 |
Recombinant Fusion Proteins/genetics/metabolism | 2 | 0.0 |
Amino Acid Sequence | 13 | 0.0 |
Xenopus laevis | 3 | 0.0 |
Cell Cycle/physiology | 4 | 1.0 |
Sequence Homology, Amino Acid | 8 | 0.0 |
G2 Phase | 4 | 2.0 |
Cell Division/physiology | 2 | 0.0 |
Chromatin/metabolism | 2 | 0.0 |
DNA-Binding Proteins/metabolism | 2 | 0.0 |
Genes, Reporter | 2 | 0.0 |
Centrosome/metabolism | 2 | 10.0 |
Nuclear Proteins/*metabolism | 3 | 0.0 |
Centrosome/*enzymology | 2 | 28.0 |
Tubulin/metabolism | 3 | 3.0 |
Conserved Sequence | 2 | 0.0 |
Sequence Alignment | 5 | 0.0 |
Neoplasm Invasiveness | 2 | 0.0 |
Apoptosis | 2 | 0.0 |
Cercopithecus aethiops | 2 | 0.0 |
DNA Damage | 2 | 0.0 |
Cell Cycle/*physiology | 2 | 0.0 |
Kinetics | 2 | 0.0 |
Mutagenesis, Site-Directed | 3 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
Up-Regulation | 2 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
Tumor Markers, Biological/*analysis | 2 | 0.0 |
Cloning, Molecular | 4 | 0.0 |
Gene Expression Regulation, Neoplastic | 4 | 0.0 |
Cell Differentiation | 2 | 0.0 |
Disease Progression | 2 | 0.0 |
Spectrum Analysis, Mass | 2 | 0.0 |
BRCA2 Protein/*metabolism | 2 | 20.0 |
Apoptosis/drug effects | 2 | 0.0 |
Crystallography, X-Ray | 2 | 0.0 |
Models, Molecular | 2 | 0.0 |
Amino Acid Motifs | 5 | 0.0 |
Phosphopeptides/chemistry/*metabolism | 3 | 75.0 |
Cell Division/*physiology | 2 | 1.0 |
Microtubules/metabolism | 2 | 1.0 |
RNA, Small Interfering/metabolism | 4 | 2.0 |
Glutathione Transferase/metabolism | 4 | 0.0 |
Point Mutation | 2 | 0.0 |
Subcellular Fractions/metabolism | 2 | 0.0 |
Caffeine/pharmacology | 2 | 2.0 |
Down-Regulation | 2 | 0.0 |
*Protein-Serine-Threonine Kinases | 2 | 0.0 |
